Escolar Documentos
Profissional Documentos
Cultura Documentos
Underneath
the
retina,
however, is a second pathway
of circulation that supplies
blood to the retina. This
systems primary component is
called the choroid. The choroid
is a network of blood vessels
situated in the wall of the eye
underneath
the
entire
retina. Here, the choroid is
shown in yellow and then the
The
choroid
is
supplied
oxygenated blood through a
number of arteries, shown here in
red, which enter the back wall of
the eye at a distance from the
optic nerve. These arteries are
called posterior ciliary arteries. In
real life, there would be several
more of these arteries extending
into the back wall of the eye.
As these arteries enter the wall of
the eye they branch into the
choroid, the vast network of
vessels underlying the retina.
After the blood has circulated through the capillaries of the choroid,
the oxygen depleted blood flows into small veins that coalesce into
larger veins.
These larger veins exit the eye and are called vortex veins.
Terminology: Perfusion
A term closely related to ischemia that you may hear is
perfusion. Perfusion has to do more precisely with the flow of a
fluid or the pouring of a fluid. Where blood flows through the
vessels of a tissue, that tissue is said to be perfused. Where there
is a lack of blood flow, the tissue is said to be nonperfused.
Testing for Retinal Ischemia
A test called a fluorescein angiogram is used to look for areas of
nonperfusion in the retina. The total extent of nonperfusion noted
on a fluorescein angiogram is one primary criterion used by many
doctors to classify cases of CRVO as either ischemic (the more
severe form of CRVO) or nonischemic (the less severe form of
CRVO).
Treatments
Many strategies have been employed in attempts to alleviate retinal
ischemia due to CRVO. Unfortunately, these interventions have not
yet been so clearly successful as to be widely adopted by the medical
community. They remain experimental. Indeed, a number of the
experimental procedures have turned out to do more harm than
good. These experimental treatments may have serious
complications and are, to varying degrees, controversial with regard
to safety and/or efficacy:
chorioretinal anastomosis
hemodilution
hyperbaric oxygen
(t-PA)
CRVO is divided into two types: non-ischemic and ischemic. Nonischemic is the less serious type of central retinal vein occlusion and is
the more common type in the United States. Initially, there may be
little impact on your vision. Ischemic CRVO is more serious, and can
either occur on its own or evolve from non-ischemic. Ischemic CRVO
will usually be accompanied by a serious change in your vision.
The cause of CRVO is the subject of debate. However, the central
retinal vein and arteries share a common vessel or sheath as they exit
the optic nerve. Any compression or damage to this sheath can cause
an occlusion in the vein. Also, a thrombus or clot may form in the
central retinal vein causing the blockage. Such a blockage results in a
backup of blood in the retina, which can lead to the production of the
hormone that stimulates neovascularization. This hormone is called
vascular endothelial growth factor or VEGF, for short. In addition to
stimulating neovascularization, VEGF can also increase leakage in the
capillaries which can lead to macular edema.
In its initial stages, there may be little or no impact on your vision.
However, it is also possible for vision loss to be rapid. As the disease
progresses, your vision will continue to deteriorate without treatment
and you may notice an increasing level of discomfort and redness, if
intraocular pressure rises due to neovascularization.